CKD Hotspots: Challenges and Areas of Opportunity

Summary: The global burden of illness from chronic kidney disease (CKD) continues to increase not only because of a higher prevalence of traditional causes of CKD, such as diabetes and hypertension, but also because of a higher than average incidence of CKD resulting from infections and unknown causes in certain geographic locations around the world (the so-called, CKD hotspots). This article summarizes the main gaps and areas of opportunity related to CKD hotspots that were discussed in a recent CKD Global Summit sponsored by the International Society of Nephrology. Gaps include the lack of a universally accepted definition of CKD hotspots and CKD of unknown etiology (CKDu), which clearly compromises our understanding of the burden, severity, and natural history of these conditions. In addition, there is scarce knowledge of the causes of CKDu, limitation regarding CKD prevention and treatment, and insufficient funding and advocacy for research and clinical care. Areas of opportunity include a better epidemiologic characterization of CKD hotspots and CKDu, improved knowledge of the causes of CKDu, prevention and treatment of CKD and end-stage kidney disease, increased advocacy and funding for research and clinical care, and improved education and awareness in CKD hotspots. Summary: The global burden of illness from chronic kidney disease (CKD) continues to increase not only because of a higher prevalence of traditional causes of CKD, such as diabetes and hypertension, but also because of a higher than average incidence of CKD resulting from infections and unknown causes in certain geographic locations around the world (the so-called, CKD hotspots). This article summarizes the main gaps and areas of opportunity related to CKD hotspots that were discussed in a recent CKD Global Summit sponsored by the International Society of Nephrology. Gaps include the lack of a universally accepted definition of CKD hotspots and CKD of unknown etiology (CKDu), which clearly compromises our understanding of the burden, severity, and natural history of these conditions. In addition, there is scarce knowledge of the causes of CKDu, limitation regarding CKD prevention and treatment, and insufficient funding and advocacy for research and clinical care. Areas of opportunity include a better epidemiologic characterization of CKD hotspots and CKDu, improved knowledge of the causes of CKDu, prevention and treatment of CKD and end-stage kidney disease, increased advocacy and funding for research and clinical care, and improved education and awareness in CKD hotspots.